Enhanced spasticity in primary progressive MS patients treated with interferon beta-1b

Neurology. 1999 Nov 10;53(8):1892-3. doi: 10.1212/wnl.53.8.1892-a.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Adjuvants, Immunologic / therapeutic use*
  • Adult
  • Disease Progression
  • Humans
  • Interferon beta-1a
  • Interferon beta-1b
  • Interferon-beta / therapeutic use*
  • Middle Aged
  • Multiple Sclerosis / drug therapy*
  • Multiple Sclerosis / physiopathology*
  • Muscle Spasticity / chemically induced*

Substances

  • Adjuvants, Immunologic
  • Interferon beta-1b
  • Interferon-beta
  • Interferon beta-1a